Rapid detection of carbapenemase activity through monitoring ertapenem hydrolysis in Enterobacteriaceae with LC-MS/MS

Bioanalysis

Volumn 5, Issue 2, 2013, Pages 147-157

  Peaper, David R ^a,b   Kulkarni, Mandar V ^c   Tichy, Alexandra N ^c   Jarvis, Michael ^d   Murray, Thomas S ^a,e   Hodsdon, Michael E ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^c M/Z Diagnostics   (United States)

^d MDS SCIEX   (Canada)

^e Quinnipiac University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEMASE; ERTAPENEM;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GROWTH; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CONCENTRATION (PARAMETERS); CORRELATION ANALYSIS; DRUG HYDROLYSIS; ENTEROBACTERIACEAE; ENZYME ACTIVITY; ENZYME SYNTHESIS; INTERMETHOD COMPARISON; LIQUID CHROMATOGRAPHY; METABOLITE; NONHUMAN; POLYMERASE CHAIN REACTION; RAPID TEST; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BACTERIOLOGICAL TECHNIQUES; BETA-LACTAMASES; BETA-LACTAMS; CHROMATOGRAPHY, LIQUID; ENTEROBACTERIACEAE; MICROBIAL SENSITIVITY TESTS; TANDEM MASS SPECTROMETRY;

EID: 84872950149     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.12.310     Document Type: Article

References (31)

1. Evans HL, Lefrak SN, Lyman J et al. Cost of Gram-negative resistance. Crit. Care Med. 35(1), 89-95 (2007). (Pubitemid 46035682)
2. Giske CG, Monnet DL, Cars O, Carmeli Y. Clinical and economic impact of common multidrug-resistant Gram-negative bacilli. Antimicrob. Agents Chemother. 52(3), 813-821 (2008). (Pubitemid 351358357)
3. Mauldin PD, Salgado CD, Hansen IS, Durup DT, Bosso JA. Attributable hospital cost and length of stay associated with health care-associated infections caused by antibiotic-resistant Gram-negative bacteria. Antimicrob. Agents Chemother. 54(1), 109-115 (2010).
4. Marchaim D, Gottesman T, Schwartz O et al. National multicenter study of predictors and outcomes of bacteremia upon hospital admission caused by Enterobacteriaceae producing extended-spectrum b-lactamases. Antimicrob. Agents Chemother. 54(12), 5099-5104 (2010).
5. Roberts RR, Hota B, Ahmad I et al. Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship. Clin. Infect. Dis. 49(8), 1175-1184 (2009).
6. Bilavsky E, Schwaber MJ, Carmeli Y. How to stem the tide of carbapenemase-producing Enterobacteriaceae? Proactive versus reactive strategies. Curr. Opin. Infect. Dis. 23(4), 327-331 (2010).
7. Arcenas RC, Spadoni S, Mohammad A et al. Multicenter evaluation of the LightCycler MRSA advanced test, the Xpert MRSA Assay, and MRSASelect directly plated culture with simulated workflow comparison for the detection of methicillin-resistant Staphylococcus aureus in nasal swabs. J. Mol. Diagn. 14(4), 367-375 (2012).
8. Verhoeven PO, Grattard F, Carricajo A et al. Quantification by real-time PCR assay of Staphylococcus aureus load: a useful tool for rapidly identifying persistent nasal carriers. J. Clin. Microbiol. 50(6), 2063-2065 (2012).
9. Calfee DP, Salgado CD, Classen D et al. Strategies to prevent transmission of methicillin-resistant Staphylococcus aureus in acute care hospitals. Infect. Control Hosp. Epidemiol. 29(Suppl. 1), S62-S80 (2008).
10. Sundsfjord A, Simonsen GS, Haldorsen B, Lundblad EW, Samuelsen O. Broad-spectrum b-lactamases in Gram-negative bacteria. Tidsskr. Nor. Lægeforen. 128(23), 2741-2745 (2008).
11. Malloy AM, Campos JM. Extended-spectrum b-lactamases: a brief clinical update. Pediatr. Infect. Dis. J. 30(12), 1092-1093 (2011).
12. Ho J, Tambyah PA, Paterson DL. Multiresistant Gram-negative infections: a global perspective. Curr. Opin. Infect. Dis. 23(6), 546-553 (2010).
13. Kumarasamy KK, Toleman MA, Walsh TR et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect. Dis. 10(9), 597-602 (2010).
14. Francis RO, Wu F, Della-Latta P, Shi J, Whittier S. Rapid detection of Klebsiella pneumoniae carbapenemase genes in Enterobacteriaceae directly from blood culture bottles by real-time PCR. Am. J. Clin. Pathol. 137(4), 627-632 (2012).
15. Hindiyeh M, Smollan G, Grossman Z et al. Rapid detection of blaKPC carbapenemase genes by internally controlled real-time PCR assay using bactec blood culture bottles. J. Clin. Microbiol. 49(7), 2480-2484 (2011).
16. Hindiyeh M, Smollen G, Grossman Z et al. Rapid detection of blaKPC carbapenemase genes by real-time PCR. J. Clin. Microbiol. 46(9), 2879-2883 (2008).
17. Schechner V, Straus-Robinson K, Schwartz D et al. Evaluation of PCR-based testing for surveillance of KPC-producing carbapenem-resistant members of the Enterobacteriaceae family. J. Clin. Microbiol. 47(10), 3261-3265 (2009).
18. Burckhardt I, Zimmermann S. Using matrix-assisted laser desorption ionization-time of flight mass spectrometry to detect carbapenem resistance within 1 to 2.5 hours. J. Clin. Microbiol. 49(9), 3321-3324 (2011).
19. Hrabak J, Walkova R, Studentova V, Chudackova E, Bergerova T. Carbapenemase activity detection by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J. Clin. Microbiol. 49(9), 3222-3227 (2011).
20. Kempf M, Bakour S, Flaudrops C et al. Rapid detection of carbapenem resistance in Acinetobacter baumannii using matrix-assisted laser desorption ionization-time of flight mass spectrometry. PLoS ONE 7(2), e31676 (2012).
21. Sparbier K, Schubert S, Weller U, Boogen C, Kostrzewa M. Matrix-assisted laser desorption ionization-time of flight mass spectrometry-based functional assay for rapid detection of resistance against b-lactam antibiotics. J. Clin. Microbiol. 50(3), 927-937 (2012).
22. Grundt A, Findeisen P, Miethke T, Jager E, Ahmad-Nejad P, Neumaier M. Rapid detection of ampicillin resistance in Escherichia coli by quantitative mass spectrometry. J. Clin. Microbiol. 50(5), 1727-1729 (2012).
23. Cockerill F. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-First Informational Supplement. Clinical and Laboratory Standards Institute, Wayne, PA, USA (2011).
24. Lefeuvre S, Venisse N, Marchand S, Bachelet M, Couet W. A simple and sensitive liquid chromatography-tandem mass spectrometry assay for the quantification of ertapenem in microdialysate. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 862(1-2), 242-245 (2008). (Pubitemid 351181306)
25. D'Avolio A, Baietto L, De Rosa FG et al. A simple and fast method for quantification of ertapenem using meropenem as internal standard in human plasma in a clinical setting. Ther. Drug Monit. 30(1), 90-94 (2008). (Pubitemid 351161104)
26. Legrand T, Chhun S, Rey E et al. Simultaneous determination of three carbapenem antibiotics in plasma by HPLC with ultraviolet detection. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 875(2), 551-556 (2008).
27. McWhinney BC, Wallis SC, Hillister T, Roberts JA, Lipman J, Ungerer JPJ. Analysis of 12 b-lactam antibiotics in human plasma by HPLC with ultraviolet detection. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 878(22), 2039-2043 (2010).
28. la Marca G, Giocaliere E, Villanelli F et al. Development of an UPLC-MS/MS method for the determination of antibiotic ertapenem on dried blood spots. J. Pharm. Biomed. Anal. 61(0), 108-113 (2012).
29. College of American Pathologists. Chemistry and Toxicology Checklist. College of American Pathologists, Northfield, IL, USA (2012).
30. Slama TG. Gram-negative antibiotic resistance: there is a price to pay. Crit. Care 12(Suppl. 4), S4 (2008).
31. Mathers AJ, Cox HL, Kitchel B et al. Molecular dissection of an outbreak of carbapenem-resistant Enterobacteriaceae reveals intergenus KPC carbapenemase transmission through a promiscuous plasmid. MBio 2(6), e00204-e00211 (2011).